JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Scope & Guideline

Driving innovation in psychopharmacology for healthier futures.

Introduction

Immerse yourself in the scholarly insights of JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1044-5463
PublisherMARY ANN LIEBERT, INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1990 to 2024
AbbreviationJ CHILD ADOL PSYCHOP / J. Child Adolesc. Psychopharmacol.
Frequency10 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801

Aims and Scopes

The Journal of Child and Adolescent Psychopharmacology focuses on the intersection of pharmacology and mental health in youth, emphasizing evidence-based practices and innovative treatment approaches. It serves as a platform for sharing research on the efficacy, safety, and psychosocial implications of psychopharmacological interventions in children and adolescents.
  1. Pharmacological Treatment of Psychiatric Disorders:
    The journal extensively covers research related to pharmacological interventions for various psychiatric conditions such as ADHD, depression, anxiety, and psychotic disorders in children and adolescents.
  2. Systematic Reviews and Meta-Analyses:
    A significant portion of publications includes systematic reviews and meta-analyses that aggregate findings from multiple studies to provide comprehensive insights into treatment efficacy and safety.
  3. Innovations in Psychopharmacology:
    The journal highlights cutting-edge research, including novel medications and treatment protocols, contributing to the advancement of psychopharmacology in pediatric populations.
  4. Longitudinal and Cohort Studies:
    Research often employs longitudinal and cohort study designs to assess the long-term effects of psychotropic medications and their impact on developmental outcomes.
  5. Pharmacogenomics and Personalized Medicine:
    The journal increasingly focuses on pharmacogenetic studies that explore genetic factors influencing medication response, aiming to enhance personalized treatment approaches for youth.
  6. Behavioral and Psychosocial Interventions:
    In addition to pharmacological studies, the journal includes research on the integration of behavioral therapies with pharmacological treatments to optimize outcomes in youth.
The Journal of Child and Adolescent Psychopharmacology is witnessing notable trends and emerging themes that reflect the evolving landscape of pediatric mental health research. These themes highlight the journal's responsiveness to contemporary issues in child and adolescent psychiatry.
  1. Innovative Treatment Modalities:
    There is a growing emphasis on exploring new treatment modalities, including the use of ketamine and transcranial magnetic stimulation for treatment-resistant depression, indicating a shift towards more innovative approaches in psychopharmacology.
  2. Pharmacogenetics and Personalized Medicine:
    Recent publications increasingly focus on pharmacogenetic factors that influence medication efficacy and safety, marking a significant trend towards personalized medicine in pediatric psychopharmacology.
  3. Impact of COVID-19 on Youth Mental Health:
    The journal has seen a rise in studies investigating the psychological impact of the COVID-19 pandemic on children and adolescents, emphasizing the need to address emerging mental health challenges.
  4. Metabolic Monitoring in Psychotropic Treatment:
    Research on metabolic monitoring in youth prescribed second-generation antipsychotics is becoming more prevalent, reflecting concerns about long-term health outcomes and the need for comprehensive care.
  5. Intersection of Mental Health and Developmental Disorders:
    There is an increasing trend in exploring the intersectionality of mental health issues with developmental disorders such as autism, highlighting the complexities of treatment in these populations.

Declining or Waning

While the journal continues to explore a wide array of topics in child and adolescent psychopharmacology, certain themes appear to be waning in prominence. This decline may reflect shifting research priorities or advancements in treatment methodologies.
  1. Traditional Antidepressant Studies:
    Research focusing solely on traditional antidepressants, particularly SSRIs without considering adjunct therapies or novel treatments, has decreased as newer modalities gain attention.
  2. Generalized Anxiety Disorder (GAD) Focus:
    While anxiety disorders remain a topic of interest, specific studies centered on GAD alone are less frequent, possibly as a result of a broader focus on anxiety as part of a spectrum of disorders.
  3. Pharmacotherapy for ADHD without Behavioral Interventions:
    There is a noticeable decline in studies examining pharmacotherapy for ADHD in isolation, with a growing emphasis on combined treatment approaches that integrate behavioral interventions.
  4. Longitudinal Studies on Medication Side Effects:
    The frequency of studies specifically focusing on long-term side effects of established medications is decreasing, potentially due to a shift towards understanding efficacy in broader treatment contexts.

Similar Journals

Scandinavian Journal of Child and Adolescent Psychiatry and Psychology

Exploring innovative solutions for young minds.
Publisher: SCIENDOISSN: 2245-8875Frequency: 3 issues/year

The Scandinavian Journal of Child and Adolescent Psychiatry and Psychology is a premier platform for disseminating significant research in the fields of child and adolescent mental health. Published by SCIENDO, this journal has embraced an Open Access model since 2013, promoting wider accessibility to vital findings and discussions in this pivotal area of study. With a unique focus on issues facing young individuals, it aims to bridge gaps between research, clinical practice, and policy-making. The journal invites submissions from researchers, clinicians, and practitioners worldwide, ensuring a diverse range of perspectives and contributions. By fostering scholarly dialogue and innovation, it plays an essential role in advancing knowledge and improving outcomes in child and adolescent psychiatry and psychology, making it a crucial resource for anyone invested in the mental well-being of young populations.

PSYCHIATRY AND CLINICAL NEUROSCIENCES

Elevating Research Standards in Mental Health and Neurology
Publisher: WILEYISSN: 1323-1316Frequency: 12 issues/year

PSYCHIATRY AND CLINICAL NEUROSCIENCES is a leading journal in the fields of psychiatry and clinical neurology, published by Wiley. With a commendable impact factor and a position within the prestigious Q1 quartile across multiple relevant categories—including Medicine (Miscellaneous), Neurology, and Psychiatry and Mental Health—this journal stands out for its rigorous peer-reviewed content that addresses critical issues in mental health and neurological disorders. Established in 1933, the journal has a rich history of contributing impactful research that guides both clinical practice and academic inquiry. Although it is not an open-access journal, its high relevance is underscored by its Scopus rankings, with notable percentiles in Psychiatry and Neurology, making it a vital resource for researchers, clinicians, and students looking to stay abreast of the latest advancements. Located in the United Kingdom, PSYCHIATRY AND CLINICAL NEUROSCIENCES aims to bridge the gap between theory and practical application, fostering a comprehensive understanding of the complex interplay between mental health and neurological conditions.

AMERICAN JOURNAL OF PSYCHIATRY

Advancing the Frontiers of Psychiatric Science
Publisher: AMER PSYCHIATRIC PUBLISHING, INCISSN: 0002-953XFrequency: 12 issues/year

The American Journal of Psychiatry, published by the renowned American Psychiatric Publishing, Inc., stands as a premier platform in the field of Psychiatry and Mental Health. With its inaugural edition released in 1945, this esteemed journal has consistently provided a wealth of knowledge, shaping the landscape of psychiatric research and practice globally. Notably, in the latest 2023 Scopus rankings, it achieved an impressive rank of #7 out of 567 journals in its category, placing it in the top 2% percentile, indicative of its substantial impact within the field. The journal is committed to publishing high-quality, peer-reviewed original research, clinical studies, and reviews that advance psychiatric knowledge and treatment options. Although it does not currently offer open access, its contributions are vital for researchers, clinicians, and students dedicated to improving mental health care and understanding complex mental health disorders. As an essential resource, it continues to foster scholarly communication among professionals who are at the forefront of psychiatric science.

World Psychiatry

Elevating the Dialogue in Psychiatry
Publisher: WILEYISSN: 1723-8617Frequency: 3 issues/year

World Psychiatry is a leading peer-reviewed journal dedicated to advancing the field of psychiatry and mental health. Published by WILEY and located in the United States, this esteemed journal boasts an impressive impact factor, ranking Q1 in the Psychiatry and Mental Health category for 2023. Recognized for its scholarly contributions, World Psychiatry ranks #1 out of 567 in the Scopus database for medicine in psychiatry and mental health, placing it in the top 1% of its field. The journal covers a wide scope of research topics, aiming to facilitate dialogue and innovation among researchers, professionals, and students alike. Though it does not offer open access, its comprehensive articles and analyses are accessible to a broad audience engaged in mental health studies. With converged years from 2007 to 2024, the journal continues to serve as a critical resource for the latest advancements and evidence-based practices in psychiatry.

Journal of the Canadian Academy of Child and Adolescent Psychiatry

Pioneering scholarly discourse in child and adolescent psychiatry.
Publisher: CANADIAN ACAD CHILD & ADOLESCENT PSYCHIATRYISSN: 1719-8429Frequency: 4 issues/year

Journal of the Canadian Academy of Child and Adolescent Psychiatry, published by the esteemed Canadian Academy of Child & Adolescent Psychiatry, serves as a crucial platform for scholarly discourse in the fields of Pediatrics and Psychiatry. With an ISSN of 1719-8429, this journal has been significantly contributing to the advancement of knowledge from 2006 to 2024, achieving notable recognition as a Q2 journal in both Pediatrics, Perinatology and Child Health, and Psychiatry and Mental Health categories. The journal's current Scopus rankings reflect its quality, sitting at the 70th percentile in Pediatrics and the 55th percentile in Psychiatry. Though currently not an open access journal, it provides valuable insights, research findings, and clinical implications for researchers, clinicians, and students dedicated to child and adolescent mental health. Its location in Canada underscores a commitment to advancing healthcare and mental wellness for young populations through rigorous academic inquiry.

Journal of Child and Adolescent Psychiatric Nursing

Empowering psychiatric nursing for children and adolescents.
Publisher: WILEYISSN: 1073-6077Frequency: 4 issues/year

Journal of Child and Adolescent Psychiatric Nursing is a vital resource for those engaged in the fields of nursing, psychiatry, and pediatrics, dedicated to the advance of knowledge surrounding the mental health needs of children and adolescents. Published by WILEY, this peer-reviewed journal, with ISSN 1073-6077 and E-ISSN 1744-6171, has built a reputation for excellence since its inception in 1988 and continues to contribute significant insights through 2024. The journal holds an impressive Q1 ranking in Pediatrics and a Q2 ranking in Medicine (miscellaneous), underscoring its impact within these critical areas. Enhancing its relevance, it ranks #12/25 in Nursing - Pediatrics and #17/45 in Nursing - Psychiatric Mental Health, highlighting its important niche. Although it currently does not offer open access, the journal remains essential for researchers, clinicians, and students focusing on the complexities of mental health nursing for younger populations, ultimately aiming to improve care strategies and outcomes. Discover compelling research and discussions that shape the future of psychiatric nursing practice, promoting the well-being of children and adolescents.

Journal of the Korean Academy of Child and Adolescent Psychiatry

Empowering practitioners with evidence-based research.
Publisher: KOREAN ACAD CHILD & ADOLESCENT PSYCHIATRYISSN: 1225-729XFrequency: 4 issues/year

The Journal of the Korean Academy of Child and Adolescent Psychiatry (ISSN: 1225-729X; E-ISSN: 2233-9183) stands as a pivotal resource in the fields of child and adolescent mental health, contributing significantly to the dialogue on psychiatric practices and research in South Korea and beyond. Published by the KOREAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY, this journal is recognized for its dedication to advancing the understanding of psychiatric disorders that affect children and adolescents, as evidenced by its Q3 ranking in both Pediatrics, Perinatology and Child Health and Psychiatry and Mental Health categories for 2023. Operated from Seoul, South Korea, the journal facilitates knowledge-sharing among researchers and practitioners, providing insights into clinical practices and innovative treatment methodologies. Although not openly accessible, the journal emphasizes quality over quantity in its selection of studies, making each article a valuable contribution to the field. As the journal continues to publish impactful research through 2024, it remains essential reading for those committed to the well-being of younger populations and their families.

Psychiatria i Psychologia Kliniczna-JOURNAL OF PSYCHIATRY AND CLINICAL PSYCHOLOGY

Championing open access to impactful mental health research.
Publisher: MEDICAL COMMUNICATIONSISSN: 1644-6313Frequency: 4 issues/year

Psychiatria i Psychologia Kliniczna - Journal of Psychiatry and Clinical Psychology is a vital platform for advancing the fields of psychiatry and clinical psychology, published by Medical Communications in Poland. With its ISSN 1644-6313, this Open Access journal has been providing unrestricted access to impactful research since 2005, ensuring that findings in mental health are both accessible and disseminated widely. Although currently ranked in the Q4 quartile across Clinical Psychology and Psychiatry and Mental Health categories, and with the Scopus ranks placing it at 262/311 in Clinical Psychology and 493/567 in Psychiatry, the journal serves as a crucial resource for researchers seeking to explore innovative methodologies and therapeutic interventions. The journal's aim is to enhance understanding and treatment of psychiatric disorders by facilitating the exchange of knowledge between academia and clinical practice. As it converges from 2006 to 2024, Psychiatria i Psychologia Kliniczna remains committed to publishing high-quality articles that contribute toward the evolving landscape of mental health research.

Child and Adolescent Psychiatry and Mental Health

Pioneering Research for a Brighter Future in Psychiatry
Publisher: BMCISSN: Frequency: 1 issue/year

Child and Adolescent Psychiatry and Mental Health, published by BMC, is a premier open access journal dedicated to advancing the field of mental health and psychiatric care for children and adolescents. Since its inception in 2007, the journal has fostered a global dialogue among researchers, clinicians, and policy makers by disseminating high-quality research that addresses critical issues in child and adolescent psychiatry. With an impressive Q1 ranking in Pediatrics, Perinatology and Child Health and Psychiatry and Mental Health, it holds a significant position within the academic community, ranking 28th out of 330 in its field. This standing enhances its visibility and relevance, appealing to a wide range of professionals interested in evidence-based practices. As an open access journal, it ensures that research is freely accessible to those who need it most, facilitating greater collaboration and progress. The journal is committed to publishing diverse articles that span various aspects of mental health, including preventive measures, therapeutic interventions, and the intersection of mental health with social determinants. Researchers, practitioners, and students alike will find valuable insights and innovations within its pages, making it an indispensable resource in the field.

ACTA PSYCHIATRICA SCANDINAVICA

Connecting Global Minds in Psychiatric Research
Publisher: WILEYISSN: 0001-690XFrequency: 12 issues/year

ACTA PSYCHIATRICA SCANDINAVICA is a leading journal in the field of Psychiatry and Mental Health, published by Wiley since its inception in 1926. With a strong commitment to advancing psychiatric research, this esteemed journal boasts an impressive impact factor and ranks within the top 7% of its category, reflecting its influence and relevance in the field. Operating without an Open Access model, the journal serves as a vital resource for professionals, researchers, and students keen on accessing high-quality, peer-reviewed studies focused on mental health issues. The scope of ACTA PSYCHIATRICA SCANDINAVICA spans a broad spectrum of psychiatric topics, providing a platform for groundbreaking research and clinical practice insights. Based in the United Kingdom and featuring contributions from experts worldwide, the journal continues to shape the future of psychiatric research through its rigorous publication standards and commitment to scholarly excellence.